Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hossein Asghari

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Ageing Research Reviews|September 20, 2017
Autophagy, its mechanisms and regulation: Implications in neurodegenerative diseasesMilad Moloudizargari, Mohammad Hossein Asghari, Emad Ghobadi, et al.
Journal of Cellular Physiology|July 5, 2019
Immunoregulatory role of melatonin in cancerFatemeh Moradkhani, Milad Moloudizargari, Marjan Fallah, et al.
Bioinformatics (Oxford, England)|April 8, 2020
CircMiner: accurate and rapid detection of circular RNA through splice-aware pseudo-alignment schemeHossein Asghari, Yen-Yi Lin, Yang Xu, et al.
Journal of Cellular and Molecular Medicine|October 11, 2017
Inhibition of MEK/ERK signalling pathway promotes erythroid differentiation and reduces HSCs engraftment in ex vivo expanded haematopoietic stem cellsMorteza Zarrabi, Elaheh Afzal, Mohammad Hossein Asghari, et al.
Optics Express|February 7, 2018
Time-bandwidth compression of microwave signalsMing Li, Shuqian Sun, Bo Li, et al.
Life Sciences|January 1, 2021
Therapeutic targets of cancer drugs: Modulation by melatoninMilad Moloudizargari, Fatemeh Moradkhani, Shirin Hekmatirad, et al.
Journal of Cancer Research and Clinical Oncology|March 8, 2023
Virtual screening reveals aprepitant to be a potent inhibitor of neutral sphingomyelinase 2: implications in blockade of exosome release in cancer therapyMilad Moloudizargari, Shirin Hekmatirad, Sajjad Gharaghani, et al.
The Journal of Pharmacy and Pharmacology|November 24, 2017
The role of melatonin on chemotherapy-induced reproductive toxicityHamed Haghi-Aminjan, Mohammad Hossein Asghari, Bagher Farhood, et al.
Toxicology and Applied Pharmacology|October 5, 2017
Melatonin as an angiogenesis inhibitor to combat cancer: Mechanistic evidenceNasser Hashemi Goradel, Mohammad Hossein Asghari, Milad Moloudizargari, et al.
Oncotarget|March 17, 2018
Effects of the polyunsaturated fatty acids, EPA and DHA, on hematological malignancies: a systematic reviewMilad Moloudizargari, Esmaeil Mortaz, Mohammad Hossein Asghari, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Ageing Research Reviews|September 20, 2017
Autophagy, its mechanisms and regulation: Implications in neurodegenerative diseasesMilad Moloudizargari, Mohammad Hossein Asghari, Emad Ghobadi, et al.
Journal of Cellular Physiology|July 5, 2019
Immunoregulatory role of melatonin in cancerFatemeh Moradkhani, Milad Moloudizargari, Marjan Fallah, et al.
Bioinformatics (Oxford, England)|April 8, 2020
CircMiner: accurate and rapid detection of circular RNA through splice-aware pseudo-alignment schemeHossein Asghari, Yen-Yi Lin, Yang Xu, et al.
Journal of Cellular and Molecular Medicine|October 11, 2017
Inhibition of MEK/ERK signalling pathway promotes erythroid differentiation and reduces HSCs engraftment in ex vivo expanded haematopoietic stem cellsMorteza Zarrabi, Elaheh Afzal, Mohammad Hossein Asghari, et al.
Optics Express|February 7, 2018
Time-bandwidth compression of microwave signalsMing Li, Shuqian Sun, Bo Li, et al.
Life Sciences|January 1, 2021
Therapeutic targets of cancer drugs: Modulation by melatoninMilad Moloudizargari, Fatemeh Moradkhani, Shirin Hekmatirad, et al.
Journal of Cancer Research and Clinical Oncology|March 8, 2023
Virtual screening reveals aprepitant to be a potent inhibitor of neutral sphingomyelinase 2: implications in blockade of exosome release in cancer therapyMilad Moloudizargari, Shirin Hekmatirad, Sajjad Gharaghani, et al.
The Journal of Pharmacy and Pharmacology|November 24, 2017
The role of melatonin on chemotherapy-induced reproductive toxicityHamed Haghi-Aminjan, Mohammad Hossein Asghari, Bagher Farhood, et al.
Toxicology and Applied Pharmacology|October 5, 2017
Melatonin as an angiogenesis inhibitor to combat cancer: Mechanistic evidenceNasser Hashemi Goradel, Mohammad Hossein Asghari, Milad Moloudizargari, et al.
Oncotarget|March 17, 2018
Effects of the polyunsaturated fatty acids, EPA and DHA, on hematological malignancies: a systematic reviewMilad Moloudizargari, Esmaeil Mortaz, Mohammad Hossein Asghari, et al.
Pageof 6